Philadelphia, PA, United States of America

Carlo Ballatore

USPTO Granted Patents = 9 (Patent Applications = 7)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Philadelphia, PA (US) (2012 - 2017)
San Diego, CA (US) (2006 - 2023)
La Jolla, CA (US) (2023)

Company Filing History:

6 out of 2,597

University of Pennsylvania

patents

3 out of 15,475

University of California

Oak Ridge National Laboratory

patent

5. 1 out of 8

Celmed Oncology (usa), Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391643 - Substituted amino-thiol and amino-disulfide compounds, and uses thereof (2025-08-19),

2. 11820749 - Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning and methods for making and using them (2023-11-21),

3. 11623927 - Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules (2023-04-11),

4. 9649317 - Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies (2017-05-16),

5. 9643919 - Cycloalkyl-dione derivatives and methods of their use (2017-05-09),

6. 8927586 - Thromboxane A2 (TP) receptor antagonists (2015-01-06),

7. 8530520 - Cycloalkyl-dione derivatives and methods of their use (2013-09-10),

8. 8138361 - C-10 carbamates of taxanes (2012-03-20),

9. 7001922 - Peptide deformylase activated prodrugs (2006-02-21),

Title: Exploring the Innovations of Inventor Carlo Ballatore

Introduction:

Carlo Ballatore, a prolific inventor based in Philadelphia, PA (US), has made significant contributions to the field of pharmaceuticals and medical treatments. With a total of 8 patents to his name, Ballatore's work has focused on developing antidotes for organophosphate poisoning and compounds for stabilizing microtubules.

Latest Patents:

1. Centrally active and orally bioavailable uncharged bisoxime antidotes for organophosphate poisoning: Ballatore's invention focuses on antidotes that catalyze the hydrolysis of organophosphate-inhibited human acetylcholinesterase in the central nerve system.

2. Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules: This patent includes compounds and compositions for stabilizing microtubules in patients, treating cancer, and addressing neurodegenerative diseases.

Career Highlights:

Carlo Ballatore has been associated with prestigious institutions such as the University of Pennsylvania and the University of California. His research and innovative breakthroughs have significantly impacted the fields of pharmacology and medical science.

Collaborations:

Throughout his career, Ballatore has collaborated with distinguished colleagues, including Amos B Smith, III, and Kurt R Brunden. These collaborations have led to groundbreaking research and advancements in pharmaceutical development.

Conclusion:

Inventor Carlo Ballatore's patents reflect his dedication to developing novel solutions for complex medical challenges. His contributions in the areas of antidotes for poisoning and compounds for disease treatment showcase his commitment to pushing the boundaries of innovation in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.